Evidence from clinical studies indicates that the severity of COVID-19 is positively associated with chemokine and inflammatory cytokine levels in the plasma of patients, such as TNF-α, IL-1β, IL-6, CCL2, CCL8, and CXCL9 [76, 77]. This evidence concerns the gene IL6 and COVID-19.